Alan Glassberg is Director at BIOGEN IDEC INC. (BIIB). They have made 2 open-market trades across 1 company since 2004, most recently 2008-06-19.
CIK 0001236531
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BIIB | 5,600 | $1.3M |
Shares reported on the most recent Form 4, priced at the 2008-06-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BIIB | SELL · 10b5-1 | 2008-04-29 | 2008-05-01 | $61.65 | $617K | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2007-05-30 | 2007-06-01 | $51.54 | $1.0M | -11.0% | -1.9% | -1.9% |
| BIIB | SELL · 10b5-1 | 2006-10-02 | 2006-10-03 | $44.62 | $586K | -11.0% | -1.9% | -1.9% |
| BIIB | SELL | 2004-08-04 | 2006-11-08 | $58.02 | $108K | -11.0% | -1.9% | -1.9% |
| BIIB | SELL | 2004-05-26 | 2006-11-08 | $63.38 | $118K | -11.0% | -1.9% | -1.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.